Levels of soluble Fas ligand in myocarditis

被引：54
|
作者：
Toyozaki, T
Hiroe, M
Tanaka, M
Nagata, S
Ohwada, H
Marumo, F
机构：
[1] Tokyo Med & Dent Univ, Dept Med 2, Div Cardiol, Bunkyo Ku, Tokyo 113, Japan
[2] Osaka Univ, Sch Med, Dept Genet, Osaka, Japan
[3] Chiba Univ, Sch Med, Inst Pulm Canc Res, Div Pathol, Chiba 280, Japan
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1998年 / 82卷 / 02期
关键词：
D O I：
10.1016/S0002-9149(98)00300-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Serum levels of soluble Fas Ligand (sFasL) increased with the severity of congestive heart failure (p <0.01), and the percentages of apoptotic myocytes detected by in situ DNA nick-end labeling were significantly higher in the patients with increased levels of sFasL than in those with normal levels of sFasL (p <0.05). These findings indicated that sFasL may play an important role in pathogenesis of myocarditis.
引用
收藏
页码：246 / +
页数：5
相关论文
共 50 条
  • [31] An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand
    Sato, K
    Kimura, F
    Nakamura, Y
    Murakami, H
    Yoshida, M
    Tanaka, M
    Nagata, S
    Kanatani, Y
    Wakimoto, N
    Nagata, N
    Motoyoshi, K
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (02) : 379 - 382
  • [32] Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex
    Sabri, F
    De Milito, A
    Pirskanen, R
    Elovaara, I
    Hagberg, L
    Cinque, P
    Price, R
    Chiodi, F
    JOURNAL OF NEUROIMMUNOLOGY, 2001, 114 (1-2) : 197 - 206
  • [33] Levels of soluble Fas in patients with myocarditis, heart failure of unknown origin, and in healthy volunteers
    Toyozaki, T
    Hiroe, M
    Saito, T
    Iijima, Y
    Takano, H
    Hiroshima, K
    Kohno, H
    Ishiyama, S
    Marumo, F
    Masuda, Y
    Ohwada, H
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (06): : 798 - 800
  • [34] Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis
    Sugita, S
    Taguchi, C
    Takase, H
    Sagawa, K
    Sueda, J
    Fukushi, K
    Hikita, N
    Watanabe, T
    Itoh, K
    Mochizuki, M
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (10) : 1130 - 1134
  • [35] Soluble Fas Antigen and Soluble Fas Ligand in Intrauterine Growth Restriction
    Briana, Despina D.
    Baka, Stavroula
    Boutsikou, Maria
    Liosi, Sofia
    Vraila, Venetia-Maria
    Gourgiotis, Dimitrios
    Hassiakos, Dimitrios
    Malamitsi-Puchner, Ariadne
    NEONATOLOGY, 2010, 97 (01) : 31 - 35
  • [36] Soluble Fas antigen and soluble Fas ligand in early neonatal life
    Sarandakou, A
    Protonotariou, E
    Rizos, D
    Soubassi, L
    Malamitsi-Puchner, A
    EARLY HUMAN DEVELOPMENT, 2003, 75 (1-2) : 1 - 7
  • [37] Significance of Fas/Fas ligand and soluble Fas/Fas ligand system in patients with bile duct carcinoma
    Murakami, M
    Sasaki, T
    Tsuchida, A
    Kawasaki, Y
    Morinaka, K
    Fujimoto, Y
    Kariya, K
    Kuwada, Y
    Yamasaki, S
    Kuwahara, K
    Miyata, H
    Tyayama, K
    GASTROENTEROLOGY, 2002, 122 (04) : A442 - A442
  • [38] Soluble Fas and Fas Ligand in Pregnancy: Influence of Hypertension
    Karthikeyan, Velore J.
    Lip, Gregory Y. H.
    Baghdadi, Sabah
    Lane, Deirdre A.
    Beevers, D. Gareth
    Blann, Andrew D.
    ANGIOLOGY, 2012, 63 (01) : 35 - 38
  • [39] EVALUATION OF SERUM AND FOLLICULAR FLUID LEVELS OF SOLUBLE FAS, SOLUBLE FAS LIGAND AND OXIDATIVE STRESS PARAMETERS OF PATIENTS UNDERGOING IVF
    Pekel, A.
    Gonenc, A.
    Turhan, N. Ozturk
    Kafali, H.
    Gurcan, S.
    FERTILITY AND STERILITY, 2013, 100 (03) : S507 - S508
  • [40] Matrix metalloproteinase-1, soluble Fas ligand, and soluble Fas antigen levels in patients with multiple organ dysfunction syndrome
    S Endo
    T Kasai
    T Takakuwa
    H Nakae
    Y Yamada
    K Inada
    S Taniguchi
    Critical Care, 2 (Suppl 1):
12345